Clinical Trial Update: A Feasibility Study to Assess Critical Aspects of Fluorescence Affinity Sensor (FAS) Performance and Safety Over Several Hours [Phase 1]

View source ↗

Summary

This Phase 1 feasibility study evaluated the performance and safety of a Fluorescence Affinity Sensor (FAS) over several hours in individuals with diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Snippet

Sponsor: BioTex, Inc. | Conditions: Diabetes | Phase 1 | Status: COMPLETED